Plain-English translation of NCT07463937 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of methotrexate, a well-known medication that comes as a subcutaneous injection (a shot under the skin) for rheumatoid arthritis. Researchers want to understand how well this medication works and how safe it is when used in actual clinical practice in China, rather than in a controlled laboratory setting. They're especially interested in how it works for patients who also have lung disease or heart problems.
Methotrexate is a standard treatment for rheumatoid arthritis, but most of what we know comes from controlled clinical trials. This study exists to see how the medication performs in real-world situations, where patients may have other health conditions that weren't included in earlier research.
You likely qualify if…
You likely don't qualify if…
You would continue receiving methotrexate injections as prescribed by your doctor—the study does not change your normal treatment plan. Researchers will follow you over time through visits at participating hospitals, collecting information about how you're doing, any side effects, and how well your arthritis improves. The study involves up to 10,000 participants across China divided into groups based on whether they have lung or heart conditions, so you'll be grouped with patients similar to you.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China